Results 181 to 190 of about 126,548 (250)

A sterol reductase responsible for the unusual 8(14)-unsaturation in bacterial sterol production and degradation. [PDF]

J Bacteriol
Lee AK, Giner J-L, Welander PV.
europepmc   +1 more source

Impact of incretin analogues on lipid and lipoprotein metabolism in obesity and diabetes

British Journal of Pharmacology, EarlyView.
Abstract Incretin‐based therapies have gained momentum as a key strategy for reducing cardiovascular risk in individuals with obesity and/or type 2 diabetes (T2D). It remains unclear whether the cardiovascular benefits reflect a direct reduction in atherogenic lipoproteins—namely, low‐density lipoproteins (LDL), very low‐density lipoproteins (VLDL) and
Andrea Baragetti, Giuseppe Danilo Norata
wiley   +1 more source

Obeticholic acid as an index farnesoid X receptor scaffold in metabolic dysfunction-associated steatohepatitis: a testable model for efficacy-liability separation and biomarker interpretation. [PDF]

Front Pharmacol
Liu J, Wu X.
europepmc   +1 more source

Gut microbiota as a novel therapeutic target for eating disorders and obesity

British Journal of Pharmacology, EarlyView.
The graphical abstract highlights the bidirectional interaction between the gut microbiota and central homeostatic and hedonic mechanisms regulating food intake, which contributes to overweight and obesity. It also illustrates emerging microbiota‐based biomarkers and therapeutic strategies (including prebiotics, probiotics, postbiotics, synbiotics and ...
Solveiga Samulėnaitė, Victor Mathis, Emmanuel Darcq, Aurelijus Burokas, Elena Martín‐García, Rafael Maldonado   +5 more
wiley   +1 more source

Beyond cholesterol: regression of carotid plaques in an adolescent-a case report. [PDF]

Eur Heart J Case Rep
Zou CC, Pan MQ, Wang M.
europepmc   +1 more source

Re‐thinking peripheral dysfunctions in obesity: The emerging role of sulphaceutics and sulphanutraceutics

British Journal of Pharmacology, EarlyView.
Obesity is a chronic, relapsing, multisystem disease in which cardiometabolic risk arises from excess adiposity and progressive dysfunction of peripheral organs, ultimately disrupting endocrine and metabolic crosstalk among tissues. Within this network, sulphur‐based biology, centred on hydrogen sulphide and related reactive sulphur species, has ...
Martina Smimmo, Veronica Casale, Roberta d'Emmanuele di Villa Bianca, Valentina Vellecco, Mariarosaria Bucci   +4 more
wiley   +1 more source

Effects of Dietary Sterol-Rich Yeast Hydrolysate on Serum Lipid Indices, Intestinal Morphology, Digestive Enzyme Activities, Barrier-Related Gene Expression, and Cecal Microbiota in Yellow-Feathered Broiler Breeder Hens. [PDF]

Animals (Basel)
Zhang Y, Shi Z, Li M, Si H, Fan B, Li X, Li Y, Wang X, Liu J, Xi L.   +9 more
europepmc   +1 more source

The ongoing oleoylethanolamide story: Therapeutic implications in the control of obesity and its comorbidities

British Journal of Pharmacology, EarlyView.
The global burden of obesity continues to rise, demanding effective pharmacological strategies for individuals in whom prevention alone is insufficient. Recent incretin‐based and multi‐agonist therapies have delivered unprecedented weight loss, demonstrating that the simultaneous modulation of multiple metabolic pathways can optimize body weight ...
Marzia Friuli, Alessia Campagna, Barbara Eramo, Christian Sepe, Annarita Zuena, Silvana Gaetani, Adele Romano   +6 more
wiley   +1 more source

Editorial: Essential Biomolecules Caught in the Food Web?

Frontiers in Ecology and Evolution, 2019
Dörthe C. Müller-Navarra, Dörthe C. Müller-Navarra, Liliane Ruess   +2 more
doaj   +1 more source

The Liver as the Central Regulator of Cholesterol Homeostasis: Statins, Gut Microbiota, Hepatic Inflammation, and the Proposed Oral-Gut-Liver-Artery Axis in Atherogenesis. [PDF]

Metabolites
Cannon M, Peldyak J, Campbell E.
europepmc   +1 more source